- Home
- Contributors
- MS-Leaders.org
MS-Leaders.org
CME by this Contributor
Advances in MS: Emerging Roles for Neuroprotection and Neuroregeneration
MS-Leaders.org
January 6, 2011 - January 6, 2012
With a growing artillery of potential multiple sclerosis (MS) therapies, it becomes increasingly important for clinicians to recognize that MS therapy requires a two-tiered strategy, focusing on implementation of appropriate therapies that may not only reduce relapse frequency, but that may also provide neuroprotection.
State of the Art Diagnosis and Management of Clinically Isolated Syndrome
MS-Leaders.org
September 23, 2010 - September 23, 2011
The classic diagnosis of MS requires evidence of inflammatory demyelination of the CNS, which is disseminated in both space and time. Confidently making the diagnosis following a single episode of optic neuritis, brainstem syndrome or partial myelitis -- the clinically isolated syndromes (CIS) -- should be the goal of contemporary care, as clear benefit can now be offered through early therapy.
